Short Communication
Original Article
Case Report
Review Article
Original Article
Review Article
Original Article
Original Articles
Review Article
Original Article
Below are the latest Journal of Gastrointestinal Oncology articles published online ahead of print publication.
Review Article
Transanal total mesorectal excision for rectal cancer: hype or new hope?
Pelvic exenteration for locally advanced and recurrent rectal cancer—how much more?
Diagnostic and management strategies for lateral pelvic lymph nodes in low rectal cancer—a review of the evidence
Status of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer
Endoscopic stenting in colorectal cancer
Proton beam radiotherapy for pancreas cancer
Robotic surgery in colorectal cancer: the way forward or a passing fad
Proton beam therapy for liver cancers
Heavy charged particles for gastrointestinal cancers
Proton beam radiotherapy for anal and rectal cancers
Complete mesocolic excision for colon cancer: is it worth it?
Making sense of adjuvant chemotherapy in colorectal cancer
Genomics and metagenomics of colorectal cancer
Radiation biology considerations of proton therapy for gastrointestinal cancers
Management of anastomotic leakage after rectal surgery: a review article
Hepatic metastasis from colorectal cancer
Managing elderly with colorectal cancer
Is my life going to change?—a review of quality of life after rectal resection
Surgical management of pancreatic neuroendocrine liver metastases
Original Article
Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in patients with decompensated cirrhosis
Evaluating treatment protocols for rectal squamous cell carcinomas: the Duke experience and literature
Estimation of hepatocellular carcinoma mortality using aspartate aminotransferase to platelet ratio index
Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma
Predictors of outcomes in patients with gastric cancer treated with contemporary multimodality strategies—a single institution experience
Combined conventional transarterial chemoembolization with Mitomycin and percutaneous ablation for unresectable hepatocellular carcinoma
Downstaging unresectable hepatocellular carcinoma by radioembolization using 90-yttrium resin microspheres: a single center experience
The clinical significance of simple endoscopic scoring of patients with rectal cancer after concurrent chemoradiotherapy
Interleukin-8 associated with chemosensitivity and poor chemotherapeutic response to gastric cancer
Incidence and risk factors for post-operative mortality, hospitalization, and readmission rates following pancreatic cancer resection
Proton beam re-irradiation for gastrointestinal malignancies: a systematic review
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers
Telomerase activity in the differential diagnosis of pancreatic mass
Is metastasectomy a worthy option?—The role of surgery in metastatic colon cancer to liver and lungs
Is hepatic resection better than transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis?
Preoperative elevated plasma fibrinogen level predicts tumor recurrence and poor prognosis in patients with hepatocellular carcinoma
Dose-modified gemcitabine plus nab-paclitaxel front-line in advanced pancreatic ductal adenocarcinoma with baseline hyperbilirubinemia
Patterns of care and outcomes for adjuvant treatment of pT3N0 rectal cancer using the National Cancer Database
Survival outcomes of patients with pathological stage I gastric cancer using the competing risks survival method
Short Communication
Limited bias effect of intratumoral heterogeneity on genetic profiling of hepatocellular carcinoma
DNA damage repair deficiency as a predictive biomarker for FOLFIRINOX efficacy in metastatic pancreatic cancer
Editorial
A brief overview of the use of proton beam radiotherapy for gastrointestinal cancers
Preface to the current status of colorectal cancer surgery
Case Report
A case of class 3 MEK1 mutated metastatic colorectal cancer with a non-durable tumor marker response to MEK and ERK inhibitors
Malignant gastrointestinal neuroectodermal tumor, presenting as a second malignancy after gastric adenocarcinoma: a case report and literature review
Advanced metastatic gastric adenocarcinoma identified within the placenta: a case report with literature review
A case report of paraneoplastic syndrome in ß-hCG-secreting duodenal adenocarcinoma
Palliative radiotherapy for hepatobiliary obstruction caused by colorectal metastases
Radiation-induced hepatitis masquerading as metastatic disease: the importance of correlating diagnostic imaging with treatment planning
Meet the Professor
Professor Yanghee Woo: globalization of surgical innovation for stomach cancer treatment—a long but exciting road
News
Application of the CARE guideline as reporting standard in the Journal of Gastrointestinal Oncology
- Survival of metastatic gastric cancer: Significance of age, sex and race/ethnicity
- Increasing disparity in colorectal cancer incidence and mortality among African Americans and whites: A state's experience
- Splenectomy ameliorates hematologic toxicity of hyperthermic intraperitoneal chemotherapy
- Preoperative therapies for resectable and borderline resectable pancreatic cancer
- Colorectal cancer screening using protected microRNAs
- Fluid analysis prior to surgical resection of suspected mucinous pancreatic cysts. A single centre experience
- Increasing incidence in liver cancer in Canada, 1972-2006: Age-period-cohort analysis
- Comparison of adiponectin concentration between pancreatic cancer and colorectal cancer
- The role of taxanes in the management of gastroesphageal cancer
- Primary hepatic anaplastic large cell ki-1 lymphoma and celiac disease: a casual association?
- Endoscopic ultrasonography for pancreatic cancer: current and future perspectives
- Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib